Report from the Swedish delegation in San Francisco
This year's JP Morgan changed to a digital meeting at the last moment, but many actors who had planned to participate physically were still there, including a small delegation consisting of Business Sweden, Business Region Göteborg and SwedenBIO. San Francisco with Palo Alto/Silicon Valley around the corner is a dynamic life science hot spot all year round and the meetings we had generated collaborations for the benefit of Swedish life science.
Switching up your assets - a panel discussion at the SwedenBIO Summit
One of the program items during this year's SwedenBIO Summit was "Leverage your assets" - a panel discussion where Thomas Eldered (Flerie Invest) and Carina Schmidt (Grasp Bioscience) shared their extensive experience and knowledge of company development.
NLSDays 2022: Registration is open!
Welcome back to a physical NLSDays - the largest Nordic partnering conference dedicated to the life science industry. Next year's event will take place in Malmö over two days, filled-to-the-brim with exciting content and phenomenal partnering possibilities. Register before November 1 to receive the early bird-discount!
Voices from NLSDays 2021
Genetic Analysis had over twenty partnering meetings with pharma and investors, and several that are quickly proceeding forward. The company is based in Oslo and was one of the selected NLS Invest Rising Stars. We asked CCO Anita Patel Jusnes to share her experiences of #NLSDays and tell us more about the company.
Interview with Genagon Therapeutics CEO Moa Fransson
Before NLSDays 2021, DNB conducted an interview with Genagon Therapeutics' CEO Moa Fransson. She explains why Genagon's research is important, what will happen in the company in 2021 and why NLSDays is an important platform.
Tips on the way to market
For many Swedish life science companies, entering European and international markets is the toughest part, after years of research and development. What about marketing and supervision? How should distribution be handled? And how do you think about pricing? As more and more Swedish life science companies manage to make it all the way, as seen in SwedenBIO's latest mapping of the Swedish drug pipeline, the industry's need to navigate new areas of business development increases.
How to create sustainable trading on the stock market
The life science sector is one of the strongest for listed small companies in Sweden. At the same time, competition in the sector is fierce and it is necessary to work on the issues that affect share trading. Well-functioning share trading is important for creating growth in small and medium-sized companies. Read more about how you as a company create sustainable trading on the stock exchange in the fact sheet.
Our members
"When I became CEO of a small biotech company, I realized how much time and money could be saved by working in a more integrated way and making sure that fundraising goes hand in hand with strategic decisions, business agreements, development work and exit preparations from day one."
Christina Herder of Medivir is chair of SwedenBIO's business development and financing working group.
Brännpunkt Life Science is an interview series in collaboration with SwedenBIO that focuses on the intersection of innovation, capital and health.
In the second part, Helena Strigård, CEO of SwedenBIO, analyzes the state of the industry and takes a closer look at what the year has been like for SwedenBIO and its members.
BICO winner of the SwedenBIO Award 2021
For the 15th year in a row, SwedenBIO awards the prize to a company that has distinguished itself through achievements in research and development, business development, growth and also contributed to social benefit.
SwedenBIO Summit 2020 - watch the clips afterwards
The road to the stock exchange, the importance of marketplaces, how Almi Invest invests in life science. Here you will find the clips from SwedenBIO Summit on the theme "Follow the money" and "Money talks".
Offer to you as an incubator company
Life for start-up companies was not without challenges before the effects of the corona crisis hit and the situation is now tough for many smaller companies. Now we want to help build Sweden's next generation of life science companies strong, for future export revenues and innovation power. Start-up companies of up to four employees will be able to be members of SwedenBIO for an annual fee of SEK 1000, provided that they are linked to an incubator that is a permanent member of SwedenBIO. In return, the incubator will pay a higher fee than today.
Discount on international partnering conferences
By attending conferences like BIO in the US or SwedenBIO's own Nordic Life Science Days, you have the opportunity to meet potential and existing business partners. SwedenBIO offers discounts on participation fees to a number of such meetings.
SwedenBIO's recommendation for ownership diversification
In an initiative, SwedenBIO has developed a policy for what information life science companies in the development phase should provide so that investors can make relevant assessments before an ownership spread.
